Manganese
Active ingredient
Sold as MICRO MN
- Drug class
- -
- Availability
- See label
- Routes
- Intravenous
- Markets covered
- 1
- Products on record
- 1
Overview
Manganese is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 1 | March 22, 2025 |
CACanada· Health Canada
1 product
Uses
MICRO MN (Manganese Sulfate Injection USP) is indicated for: use as a supplement to intravenous solutions given for total parenteral nutrition (TPN). Its administration in TPN solutions helps to maintain plasma manganese levels and to prevent depletion of endogenous stores of manganese and subsequent deficiency symptoms.
2 Recommended Dose and Dose Adjustments). 2 Geriatrics (≥ 65 years of age): MICRO MN is indicated for use in geriatric patients. No dosage adjustments are required.
How to take
Sources & citations
- [1]Health Canada (DPD) · 00786942 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.